Economic burden of rheumatoid arthritis: a systematic review. - Wikidata - awgldk - TriplyDB

Economic burden of rheumatoid arthritis: a systematic review.

Economic burden of rheumatoid arthritis: a systematic review.

http://www.wikidata.org/entity/Q33831406

about

Ankylosing spondylitis: an overview Global economic burden of schizophrenia: a systematic review Nanomedicine delivers promising treatments for rheumatoid arthritis A prospective pilot study to evaluate an animated home-based physical exercise program as a treatment option for patients with rheumatoid arthritis.Rheumatoid Arthritis Disease Activity Is Determinant for ABCB1 and ABCG2 Drug-Efflux Transporters Function Arthritis and the Risk of Falling Into Poverty: A Survival Analysis Using Australian Data.Low-level laser therapy for zymosan-induced arthritis in rats: Importance of illumination time.Comparing Healthcare Costs Associated with Oral and Subcutaneous Methotrexate or Biologic Therapy for Rheumatoid Arthritis in the United States.Burden of anemia in patients with osteoarthritis and rheumatoid arthritis in French secondary care The economic burden of musculoskeletal disease in Korea: a cross sectional study.Immediate determination of ACPA and rheumatoid factor--a novel point of care test for detection of anti-MCV antibodies and rheumatoid factor using a lateral-flow immunoassay Medical care expenditures and earnings losses among persons with arthritis and other rheumatic conditions in 2003, and comparisons with 1997 Adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a narrative review of the literature.Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa--a systematic review.Strengthening and stretching for rheumatoid arthritis of the hand (SARAH): design of a randomised controlled trial of a hand and upper limb exercise intervention--ISRCTN89936343.Association of the CD28/CTLA4/ICOS polymorphisms with susceptibility to rheumatoid arthritis.Cost of illness for patients with arthritis receiving multidisciplinary rehabilitation care Economic burden of neural tube defects and impact of prevention with folic acid: a literature review Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries.Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries.Determinants of direct costs in Dutch rheumatoid arthritis patients.Burden and cost of illness in patients with juvenile idiopathic arthritis Direct costs related to rheumatoid arthritis: the patient perspective.Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results.Prevalence of rheumatoid arthritis in low- and middle-income countries: A systematic review and analysis.Health economics: implications for novel antirheumatic therapies.Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany Joint surgery in the Utrecht Rheumatoid Arthritis Cohort: the effect of treatment strategy The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines Epidemiology and burden of illness of rheumatoid arthritis.Is shared care with annual hospital review better value for money than predominantly hospital-based care in patients with established stable rheumatoid arthritis?Utility and direct costs: ankylosing spondylitis compared with rheumatoid arthritis.Unmet needs in rheumatoid arthritis.Cost of rheumatoid arthritis in a selected population from Argentina in the prebiologic therapy era.Systematic review of studies of productivity loss due to rheumatoid arthritis.Head-to-head comparison of aggressive conventional therapy and three biological treatments and comparison of two de-escalation strategies in patients who respond to treatment: study protocol for a multicenter, randomized, open-label, blinded-assesso Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis.Orthopedic surgery core curriculum hip and knee reconstruction Health economic issues in rheumatoid arthritis.Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution

P2860

Q24675044-9D3B9955-C139-4411-9151-46DD83E5293A Q26764888-0354E238-E91D-48FC-B418-E38112237D30 Q27021438-147368CD-3669-4D83-910C-267669D95E59 Q27309258-E85DAF43-49D9-4364-AA4F-BCB7A0F5B06C Q28552801-19BE8E9B-F783-4955-8070-2EA0E9F6C613 Q30994490-7A1B7C21-492A-4949-B8CB-CFDD73605F3C Q33292053-EAE5DB10-203B-4BA0-AA07-25FB7D65F01D Q33572767-12F84E3F-FA93-40E1-9561-79516E7A9F8F Q33675386-E09DFA55-60D0-48E3-87C4-D01F76A19E04 Q33958892-BD1002A3-61C1-4234-96C9-33D27D5AFEAE Q34027640-281EE3D7-387B-45DD-A6D7-4DFBCCC98820 Q34079091-DF95A540-3AC6-4544-B9F6-6753C1E6A18D Q34156535-3633BC50-5BBA-44C1-A260-4A415822BA21 Q34476430-E2AB7FCF-2A75-4FEC-BD16-B94948DDC77C Q34486680-9AB03F9C-A048-4EF8-B1DD-CE2E9E56784B Q34616332-F12334E0-AAB9-4BC3-A28E-436FBCF0914E Q35368403-34C760DD-9120-4A7E-B807-48532EE47977 Q35402500-E7A67490-D6A1-4C7A-9875-A436D32B1BAE Q35551561-00FFF8C2-59A0-4766-B38D-BD54D729A339 Q35552992-6CFC9784-7598-4A45-86E2-E9F57F5D642A Q35554259-9A032310-58ED-40F2-8F38-F94CDB9D53FA Q35554270-0C0A5A53-B2AB-40F5-B6D4-3E8CFB7C61F6 Q35554873-6E3C96EF-1484-4BAB-BA53-25E144DF8224 Q35554892-12BCBB64-EAD5-46A8-BD34-259BEE49C68D Q35559454-55698942-A6E7-4C3B-8023-DDA2643C9918 Q35579507-1CE64959-EFFB-476D-AEF9-7BB43962BC0E Q35637894-E4B3CEF2-BE6A-4077-8D68-814F4A34422B Q35638133-42AA3FB5-D1B2-4063-9B33-3D2F76339179 Q35688491-B72CF23D-39D1-4D75-96D1-6D5CA9A15A17 Q35780338-9D3F7B7D-E2DD-44A8-BF40-918C40F9E859 Q35953211-9C725EAE-4775-4203-86CC-C10403C06FD3 Q35953401-AC3DBF4C-2BFB-4A28-8C22-461DDA4A4161 Q36165321-B4695A65-A46D-4011-9609-F315768CB023 Q36197850-BDE24697-61D5-4943-B7DA-8BF681BC7DAD Q36312507-537BC0BB-4DBC-46C7-BC40-CA9BC199D68A Q36334999-F47A7934-28DF-43BD-83A4-1F1FA3BE4833 Q36475642-D7ED39F1-6E74-424F-91C0-7FD63F6EB7E7 Q36661202-64D0CBF9-EE6A-4F7C-A5C8-EC4C48C44219 Q36753625-4C0A5DBA-C50F-4D57-9B04-5BE1B325AE0D Q36778450-092C23FE-BF2C-4E1A-86D5-791AC94DC80F

P2860

Economic burden of rheumatoid arthritis: a systematic review.

http://www.wikidata.org/entity/Q33831406

description

2000 nî lūn-bûn

@nan

2000 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Economic burden of rheumatoid arthritis: a systematic review.

@ast

Economic burden of rheumatoid arthritis: a systematic review.

@en

type

label

Economic burden of rheumatoid arthritis: a systematic review.

@ast

Economic burden of rheumatoid arthritis: a systematic review.

@en

prefLabel

Economic burden of rheumatoid arthritis: a systematic review.

@ast

Economic burden of rheumatoid arthritis: a systematic review.

@en

P1433

Q33831406-037336DB-8F31-4929-A132-37B50A9A891C

P1476

Q33831406-175B365E-0737-40DB-925E-3DE3D437EBF6

P2093

Q33831406-5D684640-7995-4A43-B61D-D843237950AE

P2860

Q33831406-00F7355E-487A-429D-B035-3C65A7EB1BE2

Q33831406-028F1F41-6D77-4B58-AEB8-4932C1E87F39

Q33831406-30B9F9B2-8A49-4B34-8B8E-240680B407DE

Q33831406-56950782-90D8-4D2A-A86D-5A2CC721ACFB

Q33831406-6B3880C7-8D96-4625-9A79-E2169C431D5C

Q33831406-83CF3B64-F5FF-4D04-9F31-9E39DB942E36

Q33831406-A42E4A6A-7CA4-4FAE-A733-11E617E7CB76

Q33831406-AD6D26F0-3E81-4F0B-834A-C9CDE5B673E8

Q33831406-CB1CEFAA-B46C-4229-B9E8-173A017FD2EC

Q33831406-CC924494-3145-4DA8-9E7B-2A07646C9E43

P304

Q33831406-AFD1F67F-27D0-4ECF-87B9-D4CEDDC4B6A7

P31

Q33831406-BCD8D0A9-4690-45F1-B99A-107AC8AAE153

P356

Q33831406-80788833-1EBA-46F7-8FDE-947EDB552909

P433

Q33831406-58B94229-AFD7-45AB-957A-EAFF650836F5

P478

Q33831406-2EDF0A29-0ACA-43C5-8E03-27CE0627F0BF

P577

Q33831406-7EE43769-CB5A-4217-9DC8-E5D51A5D3B10

P5875

Q33831406-75BC8FA5-CCC6-46BE-B2B8-E122B947517F

P698

Q33831406-C32A8C17-4B7D-4AEA-9BA3-14F9221371B7

P356

P1433

P1476

Economic burden of rheumatoid arthritis: a systematic review.

@en

P2093

Cooper NJ

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis and interpretation of cost data in randomised controlled trials: review of published studies.

The costs of rheumatoid arthritis.

Social and economic impacts of four musculoskeletal conditions. A study using national community-based data.

The costs of rheumatoid arthritis. A patient-oriented study of chronic disease costs.

Health economics as an aspect of health outcome: basic principles and application in rheumatoid arthritis.

Predicting the cost of illness: a comparison of alternative models applied to stroke.

Socioeconomic evaluation of rheumatoid arthritis and osteoarthritis: a literature review.

The total cost of care and the use of pharmaceuticals in the management of rheumatoid arthritis: the Medi-Cal program.

Locomotion status and costs in destructive rheumatoid arthritis. A comprehensive study of 82 patients from a population of 13,000.

A multicenter study of annual health service utilization and costs in rheumatoid arthritis.

P304

28-33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/RHEUMATOLOGY/39.1.28

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P577

2000-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12651895

http://www.w3.org/2001/XMLSchema#string

P698

10662870

http://www.w3.org/2001/XMLSchema#string